Ambient AI scribes may be the biggest healthcare development of 2025. Even with no mandate and no reimbursement change. They spread because doctors are drowning in documentation. But while well-being gains are celebrated, a coding arms race is taking shape:

Special thanks to our speakers: Natalia Trayanova @mdredze.bsky.social @alexisbattle.bsky.social @tinglongdai.com Haris Sair Alex Baras Rick Carrick Robert Stevens Ashley Kieman Agbessi Amouzou

FDA-cleared #AI medical devices often experience recalls shortly after clearance, particularly those without clinical validation and produced by publicly traded companies. ja.ma/3UFrZqI

Medical AI is as much about forgetting as it is about learning. Even if data are deleted, models can still remember what they learned. That’s why “machine unlearning” is emerging as a crucial frontier for privacy, regulation, and trust. New in Health Affairs: www.healthaffairs.org/content/fore...

FDA-cleared #AI medical devices often experience recalls shortly after clearance, particularly those without clinical validation and produced by publicly traded companies. ja.ma/4lFOjeA

In our new @jamahealthforum.com paper, we examined timing and drivers of FDA-cleared AI medical device recalls We show publicly traded companies’ products are far more likely to be recalled. Such recalls often occur within 1st year & with no human testing Read more: jamanetwork.com/journals/jam...

A study finds clinicians rate peers who use generative AI for primary decision-making lower in skill and competence. Framing AI as a verification tool partially mitigates this negative perception but does not eliminate it. #MedSky #MLSky #MedAI

Would you trust a doctor who uses ChatGPT during your visit? Today, we published a study in @natureportfolio.nature.com Digital Medicine — the first survey of practicing clinicians on how they view peers who use generative AI in medical decision-making. 🔗 nature.com/articles/s41...

With Mariana Socal of @johnshopkinssph.bsky.social & Maqbool Dada of [email protected], in Health Affairs Scholar @healthaffairs.bsky.social: “Prescription for made in America? Tariffs and U.S. drug manufacturing” url: academic.oup.com/healthaffair...

Honored to lead an incredible team of @jhu.edu medical students on the first full look at how @fda.gov-cleared medical AI devices are developed and commercialized, now in @ai.nejm.org. We tracked 950 AI medical devices. The results may surprise you: bit.ly/fdaai25 (1/7)

"It's not just about higher costs -- it's about readiness." -- @tinglongdai.com, of @jhu.edu, on the threat that tariffs pose to #publichealth preparedness. www.medpagetoday.com/special-repo...

1/5 Quoted in @nature.com on how Trump’s tariffs are hitting the supply chain for science: www.nature.com/articles/d41... via @celestebiever.bsky.social These tariffs influence all facets of global trade, affecting the U.S.'s role as a leading importer and exporter.​

Microscopes, test tubes and other research supplies are about to get more expensive thanks to Trump tariffs. “We're already doing quotes today that are 20% more than they were yesterday” www.nature.com/articles/d41... @nature.com @tinglongdai.bsky.social

Trust in AI-assisted health systems and AI’s trust in humans - By Madeline Sagona, Tinglong Dai, Mario Macis & Michael Darden | npj Health Systems www.nature.com/articles/s44...

Trust in AI-assisted health systems and AI's trust in humans ->Nature | #Health #AI | More info from EcoSearch

1/ Can we trust AI to deliver health care? And can AI trust us? www.nature.com/articles/s44... So excited to share our new perspective in @natureportfolio.nature.com Digital Medicine, written with the brilliant Madeline Sagona, Mario Macis, & Michael Darden.